MMJ International Holdings New FDA Multiple Sclerosis Study Pushes Cannabis Components Closer To FDA Approval
MMJ's first clinical trial of cannabis-based medicines involving patients suffering from Multiple Sclerosis and its related forms of severe pain and spasticity will be seeking FDA permission to pr...
Page (1) of 1 - 06/11/18||
(June 11, 2018)
This article is no longer available,but here are some related topics.
HTN - Health Technology Net
DMN Newswire Newsletter
All Rights Reserved